Compare StocksCRM vs IDXX

Salesforce, Inc. (CRM) vs IDEXX Laboratories, Inc. (IDXX): Which Is the Better Buy in 2026?

As of 2026-06-19, CRM is undervalued at $152, with a DCF intrinsic value of $274 and a margin of safety of 45%. IDXX is overvalued at $562, with an intrinsic value of $382 and a margin of safety of -47%. Of the two, CRM has the wider margin of safety.

CRM
Salesforce, Inc.
$151.78
VS
IDXX
IDEXX Laboratories, Inc.
$562.09

Rewards

CRM
  • Gross margin of 77.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Free cash flow has grown at a 31.6% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $5.53 of earning power — management is an exceptional capital allocator.
IDXX
  • IDEXX Laboratories, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 62.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • IDEXX Laboratories, Inc. scores 99/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.

Risks

CRM
    IDXX
    • FCF yield of 2.4% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
    • PEG ratio of 3.67 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
    • 14 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

    Key Valuation Metrics

    Learn more →
    CRM
    IDXX
    Valuation
    $16.55B
    Free Cash Flow
    $1.04B
    13.32%
    FCF Yield
    2.35%
    17.57
    Trailing P/E
    41.39
    9.77
    Forward P/E
    34.03
    Quality & Moat
    9.61%
    ROIC
    41.94%
    16.91%
    ROE
    72.91%
    77.64%
    Gross Margin
    62.05%
    0.77
    PEG Ratio
    3.67
    Balance Sheet Safety
    0.90
    Net Debt / Equity
    0.58
    N/A
    Interest Coverage
    N/A
    2.38
    Net Debt / EBITDA
    0.59
    1.09%
    Dividend Yield
    0.00%
    CRM: 7Ties: 1IDXX: 4
    CRMIDXX

    Historical Fundamentals

    Learn more →
    CRM

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    IDXX

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    CRM
    $-7.99
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $14.67B
    Δ Market Cap
    $-117.14B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    IDXX
    $7.20
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $2.79B
    Δ Market Cap
    +$20.11B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    CRM
    44.5% Margin of Safety
    Price is 44.5% below estimated fair value
    Current Price: $151.78
    Fair Value: $273.71
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    IDXX
    47.3% Overvalued
    Price is 47.3% above estimated fair value
    Current Price: $562.09
    Fair Value: $381.58
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    CRM

    What growth rate is the market pricing in at $152?

    +3.6%
    Market-Implied Owner Earnings Growth
    Standard FCF implies -2.8%

    The market implies +3.6% Owner Earnings growth, below historical trends — potential opportunity.

    Standard FCF implies a more demanding -2.8%, reflecting heavy growth investment expected to generate future returns.

    IDXX

    What growth rate is the market pricing in at $562?

    +17.9%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +18.3%

    The market implies +17.9% Owner Earnings growth, roughly in line with history — reasonably priced.

    Standard FCF implies +18.3%, reflecting ongoing growth investment.

    Economic Moat Score

    Learn more →
    CRM
    58/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    IDXX
    99/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    CRM
    -2.73
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    IDXX
    -2.50
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    CRM
    Insiders 3.0%Institutions 94.3%Retail & Other 2.8%
    No. of Institutional Holders3,722
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    IDXX
    Insiders 0.2%Institutions 96.2%Retail & Other 3.6%
    No. of Institutional Holders1,864
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    CRM
    0
    Buys (3M)
    5
    Buys (12M)
    Total value (12M): $27.38M
    ALBER LAURA
    Director
    $500,266
    @ $194.58 · 2026-03-19
    KIRK DAVID BLAIR
    Director
    $500,178
    @ $194.62 · 2026-03-18
    KIRK DAVID BLAIR
    Director
    $500,722
    @ $258.64 · 2025-12-17
    MORFIT G MASON
    Director and Beneficial Owner of more than 10% of a Class of Security
    $25.02M
    @ $260.58 · 2025-12-05
    KIRK DAVID BLAIR
    Director
    $865,827
    @ $254.66 · 2025-09-09
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    IDXX
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    CRM
    0
    Sells (3M)
    15
    Sells (12M)
    Total value (12M): $40.30M
    KROES NEELIE
    Director
    $929,276
    @ $238.70 · 2026-01-14
    HARRIS G PARKER
    Officer and Director
    $31.61M
    @ $234.70 · 2025-12-02
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $575,140
    @ $255.62 · 2025-10-23
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $590,102
    @ $262.27 · 2025-10-21
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $567,631
    @ $252.28 · 2025-10-20
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $550,430
    @ $244.64 · 2025-10-17
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $558,810
    @ $248.36 · 2025-10-16
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $536,322
    @ $238.37 · 2025-10-15
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $548,796
    @ $243.91 · 2025-10-14
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $1.10M
    @ $244.75 · 2025-10-13
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $547,344
    @ $243.26 · 2025-10-09
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $539,533
    @ $239.79 · 2025-10-08
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $555,001
    @ $246.67 · 2025-09-23
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $552,798
    @ $245.69 · 2025-09-19
    BENIOFF MARC RUSSELL
    Chief Executive Officer
    $545,384
    @ $242.39 · 2025-09-15
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    IDXX
    0
    Sells (3M)
    14
    Sells (12M)
    Total value (12M): $70.78M
    HUNT NIMRATA K
    Officer
    $1.12M
    @ $634.57 · 2026-03-03
    MAZELSKY JONATHAN JAY
    Chief Executive Officer
    $15.34M
    @ $657.55 · 2026-02-26
    HUNT NIMRATA K
    Officer
    $1.78M
    @ $661.54 · 2026-02-26
    VANDEBROEK SOPHIE V
    Director
    $920,293
    @ $628.62 · 2026-02-17
    ERICKSON MICHAEL G
    Officer
    $3.37M
    @ $627.38 · 2026-02-17
    FENNELL GEORGE
    Officer
    $7.34M
    @ $646.72 · 2026-02-10
    HUNT NIMRATA K
    Officer
    $6.63M
    @ $703.34 · 2025-11-07
    SZOSTAK MARGARET ANNE
    Director
    $1.42M
    @ $647.33 · 2025-08-22
    ERICKSON MICHAEL G
    Officer
    $263,813
    @ $651.39 · 2025-08-12
    HUNT NIMRATA K
    Officer
    $787,840
    @ $656.53 · 2025-08-11
    UNDERBERG SHARON E
    General Counsel
    $3.55M
    @ $651.60 · 2025-08-08
    MAZELSKY JONATHAN JAY
    Chief Executive Officer
    $18.49M
    @ $631.98 · 2025-08-06
    LANE MICHAEL J
    Officer
    $5.28M
    @ $627.74 · 2025-08-06
    HUNT NIMRATA K
    Officer
    $4.50M
    @ $630.43 · 2025-08-06
    JUNIUS DANIEL M
    Director
    $1.36M
    @ $506.41 · 2025-05-13
    VANDEBROEK SOPHIE V
    Director
    $628,425
    @ $491.34 · 2025-05-09
    FENNELL GEORGE
    Officer
    $4.62M
    @ $462.53 · 2025-02-10
    VANDEBROEK SOPHIE V
    Director
    $144,630
    @ $420.44 · 2024-11-27
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    CRM
    FearGreed
    🥶Extreme Fear(18/100)

    "Mr. Market is panicking — potential buying opportunity if fundamentals are strong"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    IDXX
    FearGreed
    😐Neutral(41/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    CRM
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Extreme Fear (18)
    IDXX
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (41)
    View CRM Full AnalysisView IDXX Full Analysis

    Frequently Asked Questions: CRM vs IDXX

    Is Salesforce, Inc. or IDEXX Laboratories, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, CRM trades at a 44.5% margin of safety (intrinsic value $274 vs. price $152), compared to IDXX's -47.3% margin of safety (intrinsic $382 vs. $562).

    Which stock has a wider economic moat, Salesforce, Inc. or IDEXX Laboratories, Inc.?

    IDXX scores 99/100 (Wide moat), while CRM scores 58/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is Salesforce, Inc. in financial distress?

    CRM's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. IDXX scores 23.9 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which company has better free cash flow, Salesforce, Inc. or IDEXX Laboratories, Inc.?

    Salesforce, Inc. (CRM) generates a 13.3% free cash flow yield, compared to IDEXX Laboratories, Inc.'s 2.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, Salesforce, Inc. or IDEXX Laboratories, Inc.?

    IDXX earns 41.9% ROIC versus CRM's 9.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    CRM vs IDXX: Which Is the Better Buy in 2026? | SafetyMargin.io